CIMG Inc. revenue collapses to $22.9K; equity restored but cash low, inventory $4.6M

CIMG Inc. (OTCBB: NUZE) - short, direct update on what's happening inside the company and the income statement.

Quick facts & headline numbers (quarter ended Dec 31, 2024)
- Revenues, net: $22,853 (prior: $965,932)
- Gross profit: $15,479 (prior: $124,534)
- Operating expenses: $1,517,758 (prior: $2,145,642)
- Loss from operations: $(1,502,279) (prior: $(2,021,108))
- Net loss: $(1,536,249) (prior: $(2,148,611))
- Basic & diluted loss per share: $(0.17) (prior: $(1.84)) - weighted avg shares 8,982,676 vs 1,168,221
- Cash: $124,715 (Sept 30, 2024: $464,222)
- Inventories: $4,608,307 (raw materials $4,540,113; finished goods $68,194)
- Total current liabilities: $3,640,244 (Sept 30, 2024: $6,238,323)
- Stockholders' equity: $1,527,570 (turned positive from $(650,668))

What's happening inside the company
- Strategic pivot and corporate changes: Formerly "Nuzee, Inc.", the company changed name/ticker to CIMG Inc. and is expanding from single‑serve coffee into a broader consumer food & beverage distribution model focused on Asia. Discontinued/sold certain NuZee subsidiaries earlier in 2024.
- Capital transactions and dilution: Multiple convertible note financings and private placements in FY24/FY25. Large December 2024 private placement ($10M) converted into shares (subsequent issuance of 19,457,618 shares reported). June 2025 share sale raised $1,068,480 for 6,000,000 shares. These capital raises repaired balance sheet deficits but materially diluted existing holders.
- Operations: Sales shifted geographically - virtually all reported revenue for the quarter came from PRC ($22,853); North America revenue was $0. One customer (Customer LXM) accounted for 59% of the quarter's revenue (but that revenue is tiny).
- Legal & contingency items: Settlement paid $125,000 in employment claim (Curtin). Ongoing suits include the Kim litigation (claim ~$1,041,216) and a March 2025 Ex‑Directors claim seeking >$200,000.

Income statement - positives
- Operating expense reduction: Operating expenses fell to $1.52M from $2.15M year-over-year, reflecting cost cutting versus prior quarter.
- Smaller absolute loss: Net loss narrowed from $(2.15M) to $(1.54M).
- Gross profit remains positive: Though revenue collapsed, the company still reported a positive gross margin ($15,479), indicating cost of goods sold remained below revenues for product shipped.
- Balance sheet improvement via financing: Total liabilities materially reduced (from $6.24M to $3.64M) and equity moved back into positive territory ($1.53M) thanks to conversions and equity issuances.

Income statement & financial health - negatives / risks
- Revenue collapse: Revenue plunged from $965,932 to $22,853 - a catastrophic drop in sales volume or customer base for the quarter.
- Working capital tied up in inventory: Inventories of $4.61M are large relative to cash ($124,715) and current revenues - risk of obsolescence or slow turns.
- Liquidity pressure: Cash burned from operations $(1.34M) in the quarter; cash balance fell to $124,715. Management's statement that current capital is sufficient only for the next three months is a red flag requiring additional financing.
- Heavy dilution: Weighted average shares jumped (8.98M vs 1.17M) - per‑share loss improved mainly from dilution, not operational profitability.
- Customer concentration and geography: Revenue concentrated in one small customer and a single region (PRC) - fragile revenue base.
- Significant noncash and one‑time items: Stock compensation $523,680 booked in the quarter; professional fees high ($642,125) contributing to operating expense load.
- Legal exposure: Ongoing litigation (Kim claim, Ex‑Directors claim) could lead to material cash payouts or further distraction.

Bottom line - concise view
CIMG Inc. has used convertible notes and equity issuances to straighten its balance sheet and reduced operating expense, producing a smaller absolute quarterly loss and restored positive equity. But revenue collapsed nearly to zero, cash is low ($124,715), and $4.6M of inventory ties up capital while the business model is being retooled toward new product lines and geographic focus. The company remains dependent on further financing, faces litigation risk, and has materially diluted equity holders in the process. Investors should treat any per‑share improvement with caution - it's driven by dilution and financings, not by a sustained recovery in sales.

Key documents / source: CIMG Inc. Form 10‑Q for quarter ended December 31, 2024 (consolidated balance sheet, statements of operations and cash flows).